FindTrial
Sign In

The Efficiency of Continuous Regional Intra-arterial Infusion in the Treatment of Infected Pancreatic Necrosis

The protective mechanism of lipoxin A4 in the pancreatitis associated lung injury model: tumor necrosis factor mediated inflammatory pathways and death pathway

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-12002670
Enrollment
Unknown
Registered
2012-08-09
Start date
1995-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infected Pancreatic Necrosis

Interventions

control group:treated surgically
intervention group:treated by CRAI with protease inhibitors in combination of the antibiotics

Sponsors

The First Affiliated Hospital of Wenzhou Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
47 Years to 80 Years

Inclusion criteria

Inclusion criteria: All patients must meet the diagnostic criteria for SAP [18], the following criteria: 1) temperature >=38 degree C; 2) White blood cells count >=20*10^9/L; 3) signs of peritoneal irritation in two or more quadrants; 4) signs of infected pancreatic necrosis on the CT scan (bubble), and verified bacterial growth obtained by fine needle aspiration or intra-operative culture.

Exclusion criteria

Exclusion criteria: not meet the diagnostic criteria above or meet the above diagnostic criteria, but not agree to participate in this experiment

Design outcomes

Primary

MeasureTime frame
Evaluation of IPN;Survival;Incidence of complications;Conversion to open operation/reoperation rate;Duration of hospitalization (DH);Costs of hospitalization (HC);—

Countries

China

Contacts

Public ContactMengtao Zhou
drzhoumengtao@hotmail.com+86 13806697558

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026